Prestige Consumer Healthcare Inc (PBH) Expected to Announce Earnings of $0.70 Per Share

Share on StockTwits

Equities analysts expect Prestige Consumer Healthcare Inc (NYSE:PBH) to post earnings per share (EPS) of $0.70 for the current quarter, according to Zacks. Four analysts have provided estimates for Prestige Consumer Healthcare’s earnings, with estimates ranging from $0.69 to $0.72. Prestige Consumer Healthcare reported earnings per share of $0.62 in the same quarter last year, which suggests a positive year over year growth rate of 12.9%. The company is scheduled to issue its next earnings report on Thursday, May 9th.

According to Zacks, analysts expect that Prestige Consumer Healthcare will report full year earnings of $2.77 per share for the current year, with EPS estimates ranging from $2.75 to $2.78. For the next fiscal year, analysts anticipate that the firm will post earnings of $2.83 per share, with EPS estimates ranging from $2.80 to $2.85. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Prestige Consumer Healthcare.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, February 7th. The company reported $0.73 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.71 by $0.02. The firm had revenue of $241.40 million during the quarter, compared to analysts’ expectations of $241.40 million. Prestige Consumer Healthcare had a return on equity of 11.85% and a net margin of 6.44%. The company’s quarterly revenue was down 10.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.70 EPS.

Several brokerages have weighed in on PBH. Zacks Investment Research cut Prestige Consumer Healthcare from a “hold” rating to a “sell” rating in a report on Friday, January 25th. Desjardins cut Prestige Consumer Healthcare to a “hold” rating and set a $88.00 price target for the company. in a report on Wednesday, February 13th. Royal Bank of Canada reissued a “buy” rating and set a $97.00 price target on shares of Prestige Consumer Healthcare in a report on Friday. ValuEngine cut Prestige Consumer Healthcare from a “sell” rating to a “strong sell” rating in a report on Thursday, January 10th. Finally, Raymond James cut Prestige Consumer Healthcare from an “outperform” rating to a “market perform” rating and set a $28.40 price target for the company. in a report on Tuesday, January 15th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $54.07.

Shares of NYSE PBH opened at $28.32 on Tuesday. The firm has a market capitalization of $1.47 billion, a price-to-earnings ratio of 10.98, a P/E/G ratio of 1.56 and a beta of 0.98. The company has a quick ratio of 1.34, a current ratio of 2.28 and a debt-to-equity ratio of 1.49. Prestige Consumer Healthcare has a fifty-two week low of $26.25 and a fifty-two week high of $41.76.

Institutional investors have recently bought and sold shares of the company. First Hawaiian Bank raised its holdings in shares of Prestige Consumer Healthcare by 218.4% during the 4th quarter. First Hawaiian Bank now owns 1,210 shares of the company’s stock worth $37,000 after buying an additional 830 shares in the last quarter. FNY Investment Advisers LLC acquired a new position in shares of Prestige Consumer Healthcare during the 4th quarter worth $37,000. Captrust Financial Advisors grew its position in Prestige Consumer Healthcare by 23.8% during the 4th quarter. Captrust Financial Advisors now owns 2,228 shares of the company’s stock worth $69,000 after acquiring an additional 428 shares during the last quarter. First Quadrant L P CA bought a new stake in Prestige Consumer Healthcare during the 4th quarter worth $72,000. Finally, CWM LLC grew its position in Prestige Consumer Healthcare by 31,718.2% during the 4th quarter. CWM LLC now owns 3,500 shares of the company’s stock worth $108,000 after acquiring an additional 3,489 shares during the last quarter.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Recommended Story: Cost of Debt

Get a free copy of the Zacks research report on Prestige Consumer Healthcare (PBH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.